How a South African microbiologist conquered the deadly scourge of Yellow Jack

Health · Published 3 October 2026 Swipe more like this →

In short: For centuries, yellow fever devastated tropical regions and port cities alike, often blamed on filth or slave ships. Max Theiler transformed this narrative by proving the disease was viral. His breakthrough development of the 17D vaccine saved millions, earning him the Nobel Prize and effectively ending the era of mass epidemics.

Born in Pretoria in 1899, Max Theiler eventually moved to the United States to join the Rockefeller Foundation in 1930. By that time, the scientific community had shifted away from older, erroneous theories—such as the belief that the disease was a filth-borne plague—toward an understanding of mosquito transmission. Building on the work of researchers like Walter Reed, who had confirmed the Aedes aegypti mosquito as a vector, Theiler focused on the underlying viral cause.

Theiler’s critical innovation was moving research away from expensive monkey models by demonstrating that the virus could be transmitted to mice. This shift allowed for more efficient laboratory testing. In 1937, after extensive subculturing in chicken embryos, Theiler and his colleague Hugh Smith successfully isolated an attenuated strain of the virus, which they designated 17D. This strain proved to be both safe and capable of inducing immunity, making it ideal for mass production.

The impact of this work was profound. Between 1940 and 1947, the Rockefeller Foundation distributed over 28 million doses of the 17D vaccine. This effort significantly curtailed the reach of yellow fever, which had previously been a global threat. Theiler’s contributions were recognized with the 1951 Nobel Prize in Physiology or Medicine, cementing his legacy in the history of public health and viral immunology.

Beyond his work on yellow fever, Theiler’s research spanned other viral threats, including dengue fever and Japanese encephalitis. He also identified a virus in mice that caused paralysis, now known as Theiler’s murine encephalomyelitis virus, which remains a valuable model for studying multiple sclerosis. Theiler continued his contributions to science until his death in 1972, leaving behind a career defined by rigorous laboratory investigation and life-saving medical advancement.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• A Civil War plot to spread yellow fever failed because nobody knew about mosquitoes
• The wealthy banker's son who became the father of modern vaccine science
• Why a single yellow fever vaccine dose provides lifelong protection for most travelers
• How a military surgeon turned blood serum into a weapon against deadly childhood diseases.
• The deadly 1918 pandemic that struck the young and healthy most fiercely
• The first man to undergo phalloplasty pioneered a new medical ethics
• Was Mary Seacole a pioneering nurse or a savvy entrepreneur of the Crimean War?
• The Renaissance polymath who was burned at the stake for his medical and theological ideas.
• How an unpaid researcher helped discover the essential vitamins that sustain human life
• The Irish plague doctor who became a royal physician and pioneer of modern anatomy
• How Marcello Malpighi used a rudimentary microscope to reveal the body’s hidden architecture
• How a 19th-century Russian surgeon revolutionized medicine through the study of frozen bodies

More in Medicine · More in Health · Latest · A–Z · All topics